Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)

Autor: R.E. Coleman, M. Collinson, W. Gregory, H. Marshall, R. Bell, D. Dodwell, M. Keane, M. Gil, P. Barrett-Lee, D. Ritchie, A. Bowman, V. Liversedge, R.H. De Boer, J.L. Passos-Coelho, S. O'Reilly, G. Bertelli, J. Joffe, J.E. Brown, C. Wilson, J.C. Tercero, J. Jean-Mairet, R. Gomis, D. Cameron

Publikováno v: Journal of Bone Oncology, Vol 13, Iss , Pp 123-135 (2018)

Adjuvant bisphosphonates improve disease outcomes in postmenopausal early breast cancer (EBC) but the long-term effects are poorly described. The AZURE trial (ISRCTN79831382) was designed to determine whether adjuvant zoledronic acid (ZOL) improves d

Externí odkaz: https://doaj.org/article/97c01596da034c229da91e0ecbf0b075

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The cancer registry as an ally in monitoring treatment effectiveness

Autor: L. Costa, S. Ramos, J.L. Passos-Coelho, M.I. Carvalho, Rodrigo Murteira, Filipa Alves da Costa, T. Almodovar, Catarina Ramos, Ana Miranda, M. Ferreira, M.J. Brito

Publikováno v: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Pulmonology, Vol 25, Iss 1, Pp 3-8 (2019)

This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). OBJECTIVE: To evaluate if the cancer registry database can be used to monitor treatment effectiveness using nivolumab treatment of non-s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b83e6ec7aeea2cd6f8cb96c4903e94c4
https://hdl.handle.net/10400.26/30214

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

MON-P243: Skeletal Mass Index and Visceral Mass Index as Predictors of Length of Hospital Stay of Surgical Gastrointestinal Cancer Patients

Autor: Rui Maio, João Strecht, J.L. Passos Coelho, Lisa Agostinho, Vickie E. Baracos, André F. Ferreira, R Cruz, Gonçalo Luz, Luís Gargaté, S. Velho, Fabio Lopes, Marília Cravo

Publikováno v: Clinical Nutrition. 35:S242

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d8abe318c8ad788a24dd8f3fd35ac3b3
https://doi.org/10.1016/s0261-5614(16)30877-9